Do You Need A Saudi Arabia Laboratories Market?

Growing Burden of Infectious and Chronic Diseases Will Drive Market Growth

The burden of chronic diseases in Saudi Arabia is augmenting the demand for diagnosis which is propelling the growth of the Saudi Arabia laboratories market in the forecast period.

Age-standardized mortality in Saudi Arabia decreased from 1990 to 2010 (annualized rate of change of −0·58%), and this decrease was further accelerated from 2010 to 2017 (–2·20%). 

 Saudi Arabia increased investments in health care, with an increase in domestic general government health expenditure (percentage of Gross Domestic Product [GDP]) between 2011 and 2015 of almost 68%, much higher than the North Africa and the Middle East GBD region's increase (19·2%) and the highest in 2015 among the Gulf Cooperation Council countries. This factor has increased the spending on laboratory-based tests which will drive the market in the forecast period. In 2016, as a part of Vision 2030, the ministry of health announced the transformation of the healthcare system, including three major objectives (ease access to health services, improve quality and efficiency of healthcare services, and promote prevention against health risks) focusing on improving preventive and therapeutic health-care services. In support of this action, in 2012 the Saudi Arabian ministry of health started a collaboration with the Institute for Health Metrics and Evaluation (IHME).

The Saudi Health Interview Survey has reported a high burden of nutrition-related and lifestyle-related risk factors such as obesity, hypertension, and diabetes. Substantial increases in the burden attributable to risk factors have been reported specifically among young Saudi Arabians (aged 15–24 years).

In 2010, a GBD country-specific report for Saudi Arabia reported that the country also faces an increased epidemic of non-communicable diseases and road and transportation injuries.

A survey from the National Institute of Health (NIH) has stated that the demographic composition of Saudi Arabia has changed due to the increased life expectancy and decreased fertility rate. This factor is augmenting the growth of elderly people in the country. Estimates from organizations such as NIH have suggested that 20% of people in the country will be aged above 65 years by 2050.

Added to that, Saudi Arabia is the leading country in the globe with a high prevalence of chronic diseases and their associated risk factors. For instance, one in every four adults in the country is either obese or diabetic. The prevalence of Hypertension is 25% and that of coronary heart disease is around 6%, as per the statistic of NIH.

The burden of chronic diseases in Saudi Arabia is augmenting the demand for diagnosis which is propelling the growth of the Saudi Arabia laboratories market in the forecast period.

About Us:

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within less than a year, we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: [email protected]

Tel: +1 877 441 4866

Website: www.datamintelligence.com